JERRY CAVANEAU: Open Payments
NPI 1639142284 · BRYANT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 38 payments from 13 companies in 2025. Trend: 2023 $267 · 2024 $420 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $136 |
| PFIZER INC. | 4 | $71 |
| ABBVIE INC. | 3 | $57 |
| Dexcom, Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Novo Nordisk Inc | 3 | $49 |
| Exact Sciences Corporation | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Abbott Laboratories | 1 | $22 |
Products named: MOUNJARO, Dexcom G6 Transmitter, XIFAXAN, BREZTRI, UBRELVY, ELIQUIS, TRELEGY ELLIPTA, Rybelsus.
Industry payments across AR — which companies pay providers there.
